KLRK1 and cancer: Meanwhile, the highly expression of HLA-E as a ligand for KLRC1, KLRK1, and NKG2A/CD94 on the surface of NK cells can help cancer cells evade immune killing by NK cells (Liu et al., 2023; Mac Donald et al., 2023).